Wesfarmers shares in 2025: What to expect, growth forecasts

Retail is in for an interesting year in 2025.

| More on:
Young couple at the counter of a hardware store.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

sdf

Wesfarmers Ltd (ASX: WES) shares have climbed a hefty 30% so far this year, albeit with some ups and downs along the way.

After retreating from August highs of $77.20 apiece, shares have lifted almost 9% in the past month to trade at $74.36 at the time of writing.

Looking ahead, can this retail conglomerate use its diversified portfolio to drive growth in 2025? Let's see what the experts think.

Created with Highcharts 11.4.3Wesfarmers PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

Challenges and opportunities for Wesfarmers shares

The outlook for Wesfarmers shares in 2025 will be shaped by the company's specific business lines and the economic landscape.

Analysts remain divided on the consumer discretionary stock. Goldman Sachs rates it a hold, whereas the consensus rating by brokers is a sell, according to CommSec.

Goldman's concerns are on Wesfarmers' current valuation and potentially declining margins in Kmart.

But the broker also noted the earnings power of Bunnings, along with its other growth avenues, such as healthcare and lithium.

We continue to expect Bunnings to be trading strongly and gaining share in both DIY and Trade despite a more challenging operating backdrop, and we see multiple growth options for the business as previously illustrated in our deep dive note, including Lithium and WES Health as well as Bunnings Marketplace and Retail Media.

But Wesfarmers shares are trading in line with Goldman's range of valuation estimates at a price-to-earnings (P/E) ratio of 33x, leaving the broker neutral on valuation.

It values the stock at $69.50 apiece, citing the added downside risks from lower consumer spending and a weaker retail outlook.

And Goldman may be onto something there as well.

According to the Creditor Watch 2025 Business and Economic Outlook, the retailer could "remain under some pressure" next year.

The past 12 months although prices and turnover remain much higher than before COVID. Forward orders have declined, as has profitability and business conditions.

This reflects a combination of a higher cost of living, higher interest rates and likely the pull-forward of some demand during COVID lockdowns.

Discretionary spending volumes have even declined a little, despite very strong population growth, as consumers have tightened their wallets under the aforementioned pressures.

These issues could potentially clamp discretionary spending for consumers in Australia. This could impact Wesfarmers' retail brands, including Kmart and Target, according to PAC Partners.

But at the same time, Wesfarmers is a diversified conglomerate with many lines of business.

These include non-discretionary segments, such as its healthcare portfolio and its investments in lithium.

Core business is sound

Wesfarmers shares have been pushed higher in 2024 from performance in its key brands, including Bunnings.

The home improvements warehouse continues to shine with a return on capital of 69% in FY24. Analysts expect Bunnings to remain a growth driver for the business.

Its healthcare division includes the Priceline Pharmacy and Soul Pattinson Chemist brands and isn't overly sensitive to the business cycle.

And this could be a long-term driver for the company based on broad healthcare trends.

Fidelity International says that healthcare is a "notable structural driver" due to the ageing population. It estimates that the over-65 population will double by 2050.

Meanwhile, Wesfarmers has also entered the lithium market through its stake in Covalent Lithium, which provides interesting exposure to the battery materials sector.

Wesfarmers CEO Rob Scott says the company is focused on getting its hydroxide plant up and running by mid-2025.

Wesfarmers has forecast dividends of $1.98 per share for FY25, which will grow to $2.36 by FY26 at a compound annual growth rate (CAGR) of 9.2%.

Consensus estimates also project earnings to grow at a CAGR of 9.9% over this time as well.

Foolish takeaway

Like many in the retail space, Wesfarmers shares face a challenging year ahead. High interest rates and cost-of-living pressures are weighing on consumer spending.

However, its diversified portfolio and major investments in healthcare and lithium also provide the bedrock for a running stream of earnings growth.

Even with the challenges above, consensus estimates still project the business to grow its earnings and dividends at more than 9% per year to FY26.

Wesfarmers shares have climbed 38% in the past 12 months.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Wesfarmers. The Motley Fool Australia has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Consumer Staples & Discretionary Shares

A square ballot box with an envelope going in it sits on a blue keyboard key that says 'vote'.
Consumer Staples & Discretionary Shares

Own Star Entertainment shares? Last chance to vote on 'only lifeline' left for company

Independent expert says terms of Bally's takeover unfair but the 'only lifeline' left for Star Entertainment.

Read more »

A woman sits at her home computer with baby on her lap, and the winning ticket in her hand.
Consumer Staples & Discretionary Shares

How much upside does Macquarie expect for Lottery Corporation shares?

This ASX 200 stock has proven resilient through various economic conditions.

Read more »

A smiling man take a big bite out of a burrito
Consumer Staples & Discretionary Shares

Fundie says Guzman Y Gomez share price 'looks highly attractive'. Here's why

Blackwattle Investment says Guzman Y Gomez's current valuation and risk/reward profile looks very appealing.

Read more »

a bearded man with a big smile wearing a bright red apron holds a knife in one hand and a big slab of cheese in the other as though he is about to slice it.
Consumer Staples & Discretionary Shares

What's the upside for Bega shares according to Macquarie?

This broker sees room to grow for this Aussie consumer staples company. 

Read more »

I young woman takes a bite out of a burrito n the street outside a Mexican fast-food establishment.
Broker Notes

How much upside does Macquarie see for Collins Foods shares?

The company is scheduled to report on 24 June.

Read more »

A team in a corporate office shares a pizza while standing around a table chatting about the Domino's share price.
Broker Notes

JP Morgan upgrades Domino's Pizza shares

Does the broker expect things to turn around?

Read more »

A block of cheese with grated cheese on top.
Consumer Staples & Discretionary Shares

Macquarie expects 20% upside for this ASX All Ords consumer staples stock

This week, Macquarie initiated coverage on Bega Cheese with an outperform rating.

Read more »

Man with a hand on his head looks at a red stock market chart showing a falling share price.
Consumer Staples & Discretionary Shares

Why are Cettire shares crashing 27% today?

Things aren't looking good for this online luxury products retailer.

Read more »